RGLS Regulus Therapeutics
- 2.2650
- +0.0550+2.49%
Regulus Therapeutics News
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RASTETTER WILLIAM H
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PAPADOPOULOS STELIOS
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Witz Pascale
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rosen Hugh
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nunn Jason Raleigh
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aker Christopher Ray
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CALSADA CRISPINA
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hagan Joseph P
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klassen Preston
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BALTIMORE DAVID
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huang Alice Shih-hou
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Collier Kathryn J
Regulus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Collier Kathryn J
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nunn Jason Raleigh
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rosen Hugh
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BALTIMORE DAVID
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Witz Pascale
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PAPADOPOULOS STELIOS
Regulus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RASTETTER WILLIAM H
Analysis
Price Target
No Data
